Cisplatin injection belongs to antitumor drugs, which is suitable for the palliative treatment of non-seminomatous germ cell carcinoma, advanced refractory ovarian cancer, advanced refractory bladder cancer, refractory head and neck squamous cell carcinoma and so on, and it can be used alone or in combination. Cisplatin injection is suitable for the palliative treatment of non-seminogenous germ cell carcinoma, advanced refractory ovarian cancer, advanced refractory bladder cancer, refractory head and neck squamous cell carcinoma, etc. It can be used singly or in combination with other chemotherapeutic agents, and cisplatin injection can be added on the basis of other treatments, such as surgery, radiotherapy and other treatments as appropriate. With the use of this product, patients may experience adverse reactions such as nephrotoxicity, tinnitus, treble hearing loss, neurotoxicity, bone marrow transplantation, nausea and vomiting, and allergy. Patients who are allergic to this product, pregnant women, lactating women, patients with renal dysfunction are prohibited from using this product, and patients with myelosuppression and hearing impairment should use it with caution. It is recommended that patients go to the regular hospital in time for medical consultation if they feel unwell, and follow the doctor’s instructions for symptomatic treatment. Drugs need to be used under the guidance of a doctor.